| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| KLT-1101 | KLT-1101 | Phase 2 Clinical | Kang Litai Pharmaceutical Co Ltd | Solid tumours; Leukopenia; Thrombocytopenia; Melanoma; Sarcoma, Kaposi | Details |
| Edodekin alfa | RO 247472; YM 01C | Phase 2 Clinical | Wistar Institute, Valeant, F. Hoffmann-La Roche Ltd | Breast Neoplasms; Leishmaniasis; Bacterial Infections; Melanoma; Sarcoma, Kaposi; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma; Carcinoma, Squamous Cell; Hepatitis C; Asthma; Solid tumours; Hepatitis B; Graft vs Host Disease; Carcinoma, Ovarian Epithelial; Neoplasms; Malaria; Carcinoma, Renal Cell; Abdominal Neoplasms; Squamous Cell Carcinoma of Head and Neck; HIV Infections | Details |
| GEN-1 | phIL-12-005/PPC; GEN-1; EGEN-001; IMNN-001 | Phase 2 Clinical | Expression Genetics | Cystadenocarcinoma; Ovarian Neoplasms; Cystadenocarcinoma, Serous; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid | Details |
| RTX-224 | RTX-224 | Phase 2 Clinical | Rubius Therapeutics Inc | Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung | Details |
| SON-1010 | SON-1010 | Phase 2 Clinical | Sonnet Biotherapeutics Inc | Ovarian Neoplasms; Solid tumours | Details |
| ASP-9801 | ASP-9801 | Phase 1 Clinical | Astellas Pharma Inc | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
| ANK-101 | ANK101; ANK-101 | Phase 1 Clinical | Ankyra Therapeutics Inc | Solid tumours; Soft Tissue Injuries; Skin Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| CLN-617 | CLN-617 | Phase 1 Clinical | Cullinan Oncology | Solid tumours | Details |
| KB-707 | KB-707; KB707 | Phase 1 Clinical | Krystal Biotech Inc | Solid tumours; Skin Melanoma; Carcinoma, Basal Cell; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Neoplasms; Sarcoma; Osteosarcoma; Colorectal Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
| Encapsulated pancreatic cancer vaccine(Therapyx) | PCX-12 | Phase 1 Clinical | TherapyX Inc | Pancreatic Neoplasms | Details |
| Englischer Name | Forschungscode | Forschungsphase | Firma | Frühestes Markenname | Frühestes Genehmigungsland | Früheste Indikation | Früheste Genehmigungsgesellschaft | Früheste Genehmigungsdatum | Indikationen | Klinische Studie |
|---|---|---|---|---|---|---|---|---|---|---|
| Ustekinumab biosimilar (Samsung Bioepis) | SB-17; SB17 | Approved | Samsung Bioepis Co Ltd | Pyzchiva | EU | Crohn Disease; Colitis, Ulcerative | Samsung Bioepis Nl Bv | 2024-04-19 | Gastrointestinal Diseases; Skin Diseases; Psoriasis; Arthritis, Psoriatic; Rheumatic Diseases; Colitis, Ulcerative; Inflammation; Crohn Disease; Plaque psoriasis | Details |

BettinastraBe 30, 60325 Frankfurt am Main



